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Abstract: Spin-labeling active compounds is a convenient way to prepare them 
for EPR spectroscopy with minimal alteration of the target molecule. In this 
study we present the labeling reaction of dexamethasone (Dx) with either TEMPO 
(2,2,6,6-tetramethyl-1-piperidinyloxy) or PCA (3-(carboxy)-2,2,5,5-tetramethyl-
1-pyrrolidinyloxy) with high yields. According to NMR data, both labels are 
attached at the primary hydroxy group of the steroid. In subsequent spin-stability 
measurements both compounds were applied onto HaCaT cells. When the signal 
of Dx-TEMPO decreased below the detection limit within 3 h, the signal of Dx-PCA 
remained stable for the same period of time.
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1   Introduction
The functionalization of active drugs with so-called spin labels is relevant for 
drug delivery. In this field, drugs are embedded in drug delivery devices, e.g. 
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nanoparticulate polymeric transporter, providing controlled released out of the 
polymer matrix [1, 2]. For the preclinical investigation of a drug delivery device, 
we need to understand the release mechanism and kinetics of the drug, as well 
as its fate after being released. Studies on the fate of encapsulated drugs upon 
release are usually based on UV-Vis or fluorescence spectroscopy techniques [3]. 
Both techniques require either the use of UV-Vis-active model drugs, such as Nile 
Red, or fluorescently labeled drugs [4]. Nevertheless, fluorescent labels can signifi-
cantly change the physico-chemical properties of the drug within the transporter, 
because they are complex and often large molecules (M ≥ 300 g/mol) themselves. 
Using small labels, e.g. spin labels, minimizes the change of properties, such 
as the drug’s polarity, and biological activity [5]. Spin labels, such as nitroxide-
based TEMPO and PCA, are sensitive to their chemical microenvironment and 
hence are used in biological experiments. The difference between TEMPO and 
PCA in terms of stability of the radical defines their field of application. TEMPO 
is less stable than PCA and is consequently more readily reduced to the respec-
tive hydroxylamine, while reduction of PCA typically occurs under irradiation 
[6]. The benefit of using spin labels in the field of drug delivery systems is that 
their sensitivity gives valuable information on the microenvironment of the drug 
delivery system surrounding the spin label. Combining the spin label with a drug 
molecule will therefore give us the way to track the movement of the drug inside 
and outside of the transporter by time-resolved observations [7, 8]. The drug of 
interest in our case was the poorly water soluble glucocorticoid dexamethasone 
(Dx, log P = 1.83), which is widely used as an anti-inflammatory and immunosup-
pressant agent [9, 10]. The drug molecule contains three hydroxy groups that may 
potentially serve as functional groups for attaching the carboxylic acid-contain-
ing nitroxide-based spin labels TEMPO and PCA (see Scheme 1). With respect to 
the conjugates’ further application in drug delivery, it was of great importance to 






























Scheme 1: Synthesis of spin-labeled dexamethasone with either TEMPO or PCA as spin labels.
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hydroxy group of the drug. As a single compound, the spin-labeled drug will have 
a very defined behavior within the polymeric transporter. We present an easy pro-
tocol for the selective ester bond formation between the drug’s primary hydroxy 
group and the spin label, and discuss the differences in terms of EPR performance 
between the two resulting drug conjugates.
2   Results
For the spin-labeling reaction, mild conditions had to be chosen to maintain 
the spin label’s functionality as well as possible. In this regard, the Steglich-
type esterification (see Scheme 1) was most promising. This type of reaction 
involves a carbodiimide, which, in this case, is 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) that forms the respective urea scavenging H2O, the formal 
side product of this reaction. The acyl-transfer agent 4-dimethylaminopyridine 
(DMAP) was added to prevent acyl-trapping side products [11–13]. Purification 
was performed via column chromatography which led to products in high yields 
of 90% for Dx-PCA and 88% for Dx-TEMPO. These yields were significantly higher 
than previously reported reactions between steroids and spin labels [14].
Dexamethasone exhibits three alcohol groups that can undergo esterification 
reactions, as depicted in Scheme 1. It was reported that the acyl transfer catalyst 
DMAP also works for sterically demanding tertiary alcohols [12]. In the case of the 
three sterically different hydroxy groups of dexamethasone, Steglich-type condi-
tions might potentially lead to the esterification of all three hydroxy groups of 
the steroid backbone. The conversion and reaction site were determined by mass 
spectroscopy (ESI-ToF) and NMR, respectively. ESI-ToF spectra only showed peaks 
that originated from the mono esterification, which indicated that one spin-label 
had been attached per dexamethasone molecule. In addition to ESI-ToF meas-
urements, the successful binding of the spin label to dexamethasone could be 
shown by EPR spectroscopy. Figure 1 shows the EPR signal of both the free label 
TEMPO and the Dx-TEMPO conjugate. A minimization of the high field peak indi-
cates a success in the labeling procedure. Using this spectroscopic technique, we 
further obtained information about the activity of the labels attached to the drug. 
Dx-PCA and Dx-TEMPO were compared to freshly prepared solutions of the free 
spin labels PCA and TEMPO, respectively. Both conjugates showed an EPR activ-
ity of 80% compared to the free drug. This may have been due to quenching by 
reactive species in solution.
Additionally, NMR analysis was used to determine the site of esterification. 
Prior to NMR measurements, the unpaired electron of the paramagnetic spin 
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label was reduced. The mild reducing agent formic acid was used for the reduc-
tion of Dx-TEMPO, while the relatively strong reducing agent zinc powder in com-
bination with ammonium chloride as a proton donor was used for the reduction 
of Dx-PCA to the respective hydroxylamine (see Scheme 2). Nevertheless, Dx-PCA 
showed a line broadening which indicates an incomplete reduction of the spin 
label. Even though the steroidal backbone of Dx-PCA could not be fully resolved, 
the resulting spectrum gave information on the spin label’s binding site.
Based on the spectra in Figure 2, we determined the site of esterification. The 
essential information is given by the chemical shift of the protons in positions 
A (one proton) or C (two protons) that would change upon bond formation. The 
absence of a shift of peak A or C indicates a bond formation at the tertiary hydroxy 
group at position B. In both the PCA- as well as the TEMPO-labeled conjugates, 
there was only a significant shift of the two protons of position C. Thus, the cou-
pling reactions performed under these conditions led to an esterification at the 
primary hydroxy group (C position), which is the sterically preferred position for 
the spin label attachment [14, 15]. The tertiary alcohol in the B position features 















Scheme 2: Reduction of spin-labeled dexamethasone to the respective hydroxylamines.
Fig. 1: X-band EPR spectra of TEMPO (gray) and Dx-TEMPO (black) dissolved in DMSO (0.1 mM), 
both normalized to the maximum height of the low field peak.
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followed by the secondary alcohol in position A and the primary OH-group in 
position C. By steric demand, the reactivities are reversed, the tertiary alcohol is 
most hindered and the primary least. The esterification at position C indicates 
that our reaction conditions are controlled sterically rather than electronically.
For EPR measurements in ex vivo and cell studies for treatment of skin dis-
eases, the molecular structure of the spin-labeled dexamethasone conjugates 
had to be stable for a few hours or days after application. We chose a HaCaT 
keratinocyte cell line as a test model. The stability of labeled conjugates was 
examined by treating HaCaT keratinocytes with a 0.1 mM Dx-TEMPO or Dx-PCA 
solution with PBS/glucose solution (2% DMSO content) for 180 min. PCA and 
TEMPO showed a stable EPR activity in a control experiment performed in cell 
medium in the same amount of time (for further details, see the SI). While 
Dx-TEMPO showed a fast EPR signal decay within 180  min, Dx-PCA showed 
a stable EPR signal with a marginal decrease to 93% of the initial EPR signal 
intensity (see Figure 3). This finding is in good agreement with previously pub-
lished results reporting a limited stability and increased reactivity of TEMPO in 
comparison to PCA [6, 16].
Fig. 2: Section of NMR spectra of Dx, Dx-PCA-NOH, and Dx-TEMPO-NOH (top to bottom) 
showing peak shift of CHC, which indicates bond formation to the spin label at position C of 
dexamethasone. The strong line broadening in the second spectrum is caused by residual 
radicals in the sample. Dx-TEMPO: 4.07, 4.14 ppm solvent residues.
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3   Conclusions
The applied protocols for spin-labeling dexamethasone lead to attachment of 
the spin labels PCA or TEMPO exclusively at the primary hydroxy group of dex-
amethasone in high yields, which renders the labeling protocol as highly reli-
able. EPR spectroscopy on HaCaT cells with a focus on the stability of the signal 
over time revealed that Dx-PCA was more suitable and stable than Dx-TEMPO for 
tracking the drug pathway over longer periods of time. While the EPR signal of 
Dx-TEMPO decreased to a non-detectable value within 180 min, Dx-PCA showed 
a slight decrease to only 93% of its initial intensity in the same period. We con-
clude that the more stable Dx-PCA is the conjugate of choice for biological studies 
on cells above 180  min. If studies are designed for observation periods below 
60 min, Dx-TEMPO will lead to higher temporal resolution and should hence be 
chosen. EPR spectroscopy does allow not only to track dexamethasone in bio-
logical experiments, but also to investigate its chemical environment. Choosing 
the right stability of spin labels for EPR-based cellular uptake studies can lead to 
highly temporarily resolved results and give insights on the changing surround-
ing medium of dexamethasone upon uptake. The presented spin-labeled probe 
Dx-PCA is especially of high interest for drug delivery research, as it allows to 
gain deeper insight into the transport mechanisms of new drug delivery systems.
Fig. 3: Investigation of the time-dependent stability of Dx-TEMPO and Dx-PCA (0.1 mM) solu-
tion in PBS/glucose (2% DMSO content) after application to HaCaT cells (black bars). The EPR 
intensity was measured at different time points (0 min, 60 min, 180 min) and compared to the 
respective conjugates in PBS/glucose (2% DMSO content, gray bars) without HaCaT cells. Error 
bars represent standard errors with n = 3.
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4   Experimental section
4.1   Synthesis of Dx-PCA
To a mixture of PCA in dry CH2Cl2, dexamethasone and DMAP were added under 
constant stirring. The resulting clear, pale orange solution was cooled to 0 °C for 
10 min using an ice-bath. EDC was added, stirred for 5 min at 0 °C and afterwards 
allowed to reach r.t. The reaction mixture was refluxed for 4 h. Reaction was moni-
tored using TLC (ethyl acetate). The reaction mixture was extracted with water three 
times. The collected organic phases were dried with Na2SO4, yielding a clear yellow 
solution that was afterwards evaporated to dryness under reduced pressure and 
redissolved in CHCl3. The crude product was purified using hexane/ethyl acetate 
(gradient 1:1 to 1:2) as the mobile phase. Yield: 92%. For characterization see SI.
4.2   Synthesis of Dx-TEMPO
In an ACE pressure tube, carboxyl-TEMPO (43.5  mg, 0.217  mmol, 1.3 eq) was 
dissolved in dry CH2Cl2 (40  mL), followed by the addition of dexamethasone 
(66.0 mg, 0.166 mmol) and 4-DMAP (26.4 mg, 0.216 mmol, 1.3 eq) under constant 
stirring. The resulting clear, pale orange solution was cooled to 0 °C for 10 min 
using an ice-bath. EDC (41.7 mg, 0.218 mmol, 1.3 eq) was added, stirred for 5 min 
at 0 °C and afterwards allowed to reach r.t. The reaction mixture was stirred for 
3 h and then heated under reflux. Reaction was monitored using TLC (hexane/
ethyl acetate, 1:1). The reaction mixture was extracted with water three times. The 
collected organic phases were dried with Na2SO4, yielding a clear yellow solution 
which was afterwards evaporated to dryness under reduced pressure and dis-
solved in CHCl3. The crude product was taken up on silica powder, charged into a 
chromatography column and purified using hexane/ethyl acetate (gradient 1:1 to 
1:2) as the mobile phase. Yield: 88%. For characterization see SI.
4.3   Cell culture investigations
HaCaT (human adult low calcium high temperature, secondary keratinocytes) 
cells were cultivated in RPMI 1640 medium (Gibco, Invitrogen, Carlsbad, CA, USA) 
with supplements: 1% penicillin/streptomycin (Biochrom, Berlin, Germany), 2% 
glutamine (Biochrom) and 10% FCS (PAA Laboratories, Vienna, Austria). The 
cells were cultivated in an incubator at 37 °C, 5% CO2 and 100% humidity until 
they reached a confluence of about 80% which was harvested by trypsination 
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(0.5% trypsin and 0.2% EDTA, Gibco), counted, seeded in new 75 cm2 flasks, and/
or used for further investigations [17]. To measure the EPR stability of Dx-TEMPO 
in cells, 1 × 106 cells were incubated in 1  mL PBS/glucose solution (2% DMSO 
content) with a 0.1 mM solution of the spin labeled drug in DMSO (final concen-
tration of DMSO 2%) at 37 °C, 100% humidity, and 5% CO2. After incubation, the 
cells were washed prior to EPR measurements. The baseline EPR intensity was 
measured by using glass capillaries (Hirschmann Laborgeräte GmbH & Co. KG, 
Eberstadt, Germany). TEMPO and PCA spin labels were tested for EPR signal 
stability in the above-described cell medium, and showed both no signal decay 
for 180 min. Hence, EPR measurements of TEMPO and PCA conjugates were per-
formed over 180 min. Measurements for t = 0 min were started immediately after 
the application on HaCaT cells. EPR signal intensities represent intracellular spin 
levels. For further experimental details, see SI.
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